glp 1 agonisten Comparing Ozempic, Wegovy and Other GLP-1 Drugs Current Insights, Advantages and Challenges
Description
DR, diabetic retinopathy
A Meta-Analysis of Serious Adverse Events Reported With Exenatide and Liraglutide: Acute Pancreatitis and Cancer
Taspoglutide, a novel human once-weekly GLP-1 analogue, protects pancreatic -cells in vitro and preserves islet structure and function in the Zucker diabetic fatty rat in vivo
J Neurosci (2017) 37(48):1170114
Treatment of mice with GPR40 agonists [296,297] has been reported to decrease body weight and food intake in DIO mice, effects notably absent in mice deficient for either GPR40 or GLP-1R [296]
The FDA Adverse Event Reporting System shows a likely link between GLP-1 RAs (specifically liraglutide) and increased risk of pancreatitis
